Seres Therapeutics, Inc. (Nasdaq: MCRB) announced that it is commencing an underwritten registered public offering of $60.0 million of shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE